D&D Pharmatech Inc. (디앤디파마텍): themes in its annual report
Ticker 347850, KOSDAQ
Sentences quoted from the 2025.12 annual report, filed 2026-03-20, Business Description section.
- Defense7 mentions
“Gingivalis 미생물 타겟의 치주염 치료제 개발을 위해 미국 국방부로부터 관련 특허 2건에 대한 독점실시권을 취득”
Annual report 2025.12, section: 6. 주요계약 및 연구개발활동
Text in quotes is the company's own Korean wording, not ours.
Other themes
Also from us
The same Korean filings, seen from another side.